Delivery Order SPE2DB22D3009-SPE2DB24FBB60

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $32K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,018.51, is a delivery order for the supply of 4,566,295,719 units of Naltrexone 50 mg tablets. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.01 firm fixed-price delivery order is for the supply of Naltrexone 50 mg tablets to support federal medical programs. The contract has an ultimate completion date of March 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $23,568.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4567342575 ! NALTREXONE 50 MG TABLET 60S, a medication used in the treatment of opioid and alcohol dependence. The contract has an ultimate completion date of February 24, 2025 and a firm fixed price pricing type. Amerisourcebergen holds a...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $10,354.97 for the supply of Naltrexone 50 mg tablets. The contract is issued by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Naltrexone 50 mg tablets. The $5,204.37 firm fixed price contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award, valued at $7,458.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,969,302 units of the prescription medication Naltrexone 50 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,545.05 firm-fixed-price delivery order is for the supply of 60-count bottles of 50 mg Naltrexone tablets, a medication used to treat opioid and alcohol dependence. The award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,586.59 firm fixed-price delivery order contract is for the supply of naltrexone 50 mg tablets to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract between AmerisourceBergen and the DLA Troop Support Medical, which covers a broad range of...
This federal contract award, with ID SPE2DB22D2206|SPE2DB24FHX38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,283.91, is for the delivery of Naltrexone 50 mg tablets, a medication used in the treatment of opioid and alcohol dependence. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide Naltrexone 50 mg tablets. The $13,644 firm fixed-price Delivery Order has a completion date of November 14, 2024 and does not have a set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB24FBB60
    Delivery Order

This federal contract award, valued at $31,508.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999, covers the supply of Naltrexone 50 mg tablets to support military healthcare programs. This pharmaceutical product is used in the treatment of opioid and alcohol dependence. The contract has an ultimate completion date of July 29, 2024 and utilizes a Firm Fixed Price pricing type. The award was not designated under any set-aside program, indicating open competition. Amerisourcebergen's extensive experience as a prime vendor for the DLA and other federal agencies, such as the Department of Justice Federal Bureau of Investigation, demonstrates its capabilities in providing a comprehensive range of critical medical supplies and pharmaceutical products to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/17/25, 9:46 AM